The only company conducting FDA-approved clinical trials using human embryonic stem cells (hESC) is now calling a halt to the trials. Not only have the trials stopped, but the company, Geron, which has been considered a leader in the field, indicated that it will be turning its resources to projects other than stem cell research. Read more at LifeNews.com.
Stem Cell Research Update
November 21, 2011 By